The LGBTQ Equity in HIV Prevention and Treatment Series is an online, self-paced CME accredited program composed of five, 30-minute modules addressing strategies to reduce HIV disparities among LGBTQ populations.
Content focuses on overcoming systemic barriers that persist in health access, such as literacy and education gaps, language justice, systemic discrimination, and healthcare misinformation or distrust. By highlighting these barriers and emphasizing an equity focus, the series aims to improve access to HIV prevention and treatment options among LGBTQ persons — especially those who are historically and routinely affected by the syndemics of ongoing and emerging epidemics, such as gay/bisexual Black and Latino men and transgender persons.
After completing this activity, the participant should be better able to:
This activity provides an overview of current HIV prevention and treatment options with a focus on tailoring care to the needs and preferences of LGBTQ individuals. Participants will explore patient-centered approaches to sexual history-taking, age-specific care considerations, and integration of STI prevention strategies, including DoxyPEP, into comprehensive HIV prevention planning.
Upon completion of this activity, participants will be better able to:
This activity examines the structural and systemic barriers LGBTQ individuals face when accessing HIV prevention and care services. Participants will review evidence-based strategies for improving access, such as navigation support, inclusive care models, and approaches to address stigma, documentation, and insurance-related challenges.
Upon completion of this activity, participants will be better able to:
This activity focuses on the unique epidemiologic, clinical, and social considerations relevant to transgender and gender non-conforming individuals in HIV care. Participants will gain tools to foster inclusive clinical environments, understand the role of gender-affirming care in improving HIV outcomes, and address relevant drug interactions and health disparities.
Upon completion of this activity, participants will be better able to:
This activity explores how intersecting factors such as race, ethnicity, sexuality, and systemic discrimination, impact access to HIV prevention and care for Black and Latino same-gender-loving (SGL) men. Participants will examine culturally sensitive engagement strategies that support resilience, reduce barriers, and promote equitable clinical outcomes.
Upon completion of this activity, participants will be better able to:
This activity highlights the clinical and psychosocial challenges experienced by older gay and bisexual men, particularly those aging with HIV. Participants will explore geriatric-informed care strategies, identify opportunities to address social isolation and mental health, and apply best practices for supporting lifelong prevention and care transitions.
Upon completion of this activity, participants will be better able to:
In support of improving patient care, HealthHIV is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
All modules are certified and participants can earn up to 2.75 credits/contact hours (CME, MOC, AAPA, ANCC, CPE, ASWB, APA) for completion of all program components. (5 modules).
HealthHIV designates this enduring material for a maximum of up to 2.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2.75 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Participation information will be shared through the ACCME’s Program and Activity Reporting System (PARS).
HealthHIV has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for up to 2.75 AAPA Category 1 CME credit. Approval is valid until June 16, 2026. PAs should only claim credit commensurate with the extent of their participation.
Successful completion of this nursing continuing professional development activity will be awarded up to 2.75 contact hours.
HealthHIV designates this continuing education activity for up to 2.75 contact hours (0.275 CEU) of the Accreditation Council for Pharmacy Education.
Type of Activity: Knowledge
Please check each individual module for the assigned UAN number.
As a Jointly Accredited Organization, HealthHIV is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses are approved under this program. Regulatory boards have the final authority on courses accepted for continuing education credit.
Social workers completing this course receive up to 2.75 general continuing education.
This activity was planned by and for the healthcare team, and learners will receive up to 2 .75 Interprofessional Continuing Education (IPCE) credit for learning and change.
This program has been supported by an independent educational grant from Gilead Sciences, Inc.
The planners and content/peer reviewers from HealthHIV, the accredited provider, do not have any relevant financial relationships to disclose with ineligible companies.
HealthHIV is committed to providing high quality continuing education to healthcare professionals, as individuals and teams, with a protected space to learn, teach, and engage in scientific discourse free from influence from ineligible companies that may have an incentive to insert commercial bias into education. To that end, HealthHIV requires faculty, presenters, planners, staff , and other individuals who are in a position to control the content of this CE activity to disclose all financial relationships they have had in the past 24 months with ineligible companies as defined by the ACCME, as related to the content of this CE activity, regardless of the amount or their view of the relevance to the education. All identified COI will be thoroughly vetted and mitigated according to HealthHIV policy. These disclosures will be provided to learners prior to the start of the CE activity.
This educational activity may contain discussions of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this CE activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the CE activity are those of the presenters and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this CE activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this CE activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
There are no fees for participating in or receiving credit for this CE activity. In order to receive credit, learners must participate in the entire CE activity, complete the post-test and activity evaluation form and your certificate of credit will be generated. A passing score of 80% or higher is needed to obtain credit. Your certificate will be available on eHealthHIV.org. If you have questions regarding your certificate, please contact Beth Brooks via email at [email protected].
For information on applicability and acceptance of continuing education credit for this CE activity, please consult your professional licensing board.
For Physicians requesting MOC credit, the post-test and evaluation are required in their entirety as well as your Board Unique ID number, DOB (MM/DD), and a score of 80% or higher is needed to obtain MOC credit (75% is required for ABS).
For Pharmacists, HealthHIV will accept your completed evaluation form for up to 30 days post-activity and will report your participation to the NABP only if you provide your NABP e-Profile number and DOB (MM/DD). Within 6 weeks, you can view your participation record at the NABP website: https://nabp.pharmacy/.
HealthHIV is responsible for the selection of this activity’s topics, the preparation of editorial content, and the distribution of this CE activity. Our activities may contain references to unapproved products or uses of these products in certain jurisdictions. The preparation of this activity is supported by educational grants subject to written agreements that clearly stipulate and enforce the editorial independence of HealthHIV.
The materials presented here are used with the permission of the authors and/or other sources.